Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2000 Aug;15(Suppl 1):43–50. doi: 10.1007/BF02867543

Challenges in prevention, diagnosis and therapy of emerging fungal diseases. Aspergillosis: A case study

P Usha Sarma 1,✉, P V G K Sarma 2, Taruna Madan 1
PMCID: PMC3454083  PMID: 23105267

Abstract

Diseases caused by pathogenic filamentous fungi, are an emerging threat to public health in the wake of increasing incidence of HIV and tuberculosis. At this point, discovery and development of fungal therapeutics and diagnostics are serious challenges for biomedical researchers. Recent technological advances in genomics and proteomics offer great scope for development of preventive and therapeutic measures for fungal diseases.Aspergillus, one of the medically important filamentous pathogenic fungi causes a wide spectrum of clinical disorders ranging from allergic aspergillosis to systemic invasive aspergillosis. Increase in incidence of drug resistance and the cytotoxic effects are two serious limitations of the antifungal drugs presently in use. This is primarily due to lack of understanding of biological mechanisms operative in these fungi. Today, it is possible to understand the biological mechanisms of the fungus for its colonisation, survival and invasion of the host. Future developments based on such leads can result in development of precise and specific diagnostic, therapeutic and preventive measures for a wide clinical spectrum of fungal diseases.

Key Words: Fungal diseases, aspergillosis, pathogenesis, genomics, proteomics, host's susceptibility

Full Text

The Full Text of this article is available as a PDF (670.0 KB).

References

  • 1.Mitchell T.G. Overview of Basic Medical Mycology. Otolaryngol. Clin. North. Amer. 2000;33:237–249. doi: 10.1016/S0030-6665(00)80003-1. [DOI] [PubMed] [Google Scholar]
  • 2.Sarma P.U., Banerjee B., Bir N., Kurup V.P. A. fumigatus antigen and Immunodiagnosis of ABPA. Immunol. Allergy Clin. Nor. Amer. 1998;18:525–547. doi: 10.1016/S0889-8561(05)70021-7. [DOI] [Google Scholar]
  • 3.Kurup V.P., Banerjee B., Kelly K.J., Fink JN. Molecular biology and immunology of fungal allergens. Ind. J. Clin. Biochem. 2000;15(Suppl):31–42. doi: 10.1007/BF02867542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bir N., Paliwal A., Muralidhar K., Sarma P.U. Biochemical characterisation of an immunodominant allergen/antigen ofA. fumigatus. Ind. J. Clin. Biochem. 1999;14:149–158. doi: 10.1007/BF02867913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Madan T., Arora N., Sarma P.U. Ribonuclease activity dependent cytotoxicity ofAsp fl. Mol. Cell. Biochem. 1997;175:21–27. doi: 10.1023/A:1006822906343. [DOI] [PubMed] [Google Scholar]
  • 6.Madan T., Arora N., Sarma P.U. Cytotoxicity of Asp fl, of a major allergen/antigen ofA. fumigatus. Mol. Cell. Biochem. 1997;167:89–97. doi: 10.1023/A:1006823706119. [DOI] [PubMed] [Google Scholar]
  • 7.Sarma P.U., Bir N., Paliwal A., Prasad Reddy T.L. Immunopolymerase chain reaction for detection ofAspergillus fumigatus. Ind. J. Clin. Biochem. 1997;12:101–106. doi: 10.1007/BF02873075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Banerjee B., Madan T., Sharma G.L., Prasad H.K., Nath I., Sarma P.U. Characterisation of 45 kD glycoprotein antigen ofA. fumigatus. Serodiag. Immunother. Infect. Dis. 1995;7:147–152. doi: 10.1016/0888-0786(96)87292-1. [DOI] [Google Scholar]
  • 9.Madan T., Banerjee B., Bhatnagar P.K., Shah A., Sarma P.U. Identification of 45 kD antigen in immune complexes of patients of Allergic bronchopulmonary aspergillosis. Mol. Cell. Biochem. 1997;166:111–116. doi: 10.1023/A:1006827126958. [DOI] [PubMed] [Google Scholar]
  • 10.Kolattukudy P.E., Lee J.D., Rogers L.M., Zimmerman P., Ceselski S., Fox B., Stein B., Copelan E.A. Evidence for possible involvement of an elastinolytic serine protease in aspergillosis. Infect. Immun. 1993;6:2357–2363. doi: 10.1128/iai.61.6.2357-2368.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kothari M.H., Chase T., Macmillan J.D. Correlation of elastase production by some strains ofAspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect. Immun. 1984;43:320–325. doi: 10.1128/iai.43.1.320-325.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Smith J.M., Tang C.M., Noorden S.V., Holden D.W. Virulence ofAspergillus fumigatus double mutants lacking restrictocin and an alkaline protease in a low dose model of invasive aspergillosis. Infect. Immun. 1994;62:5247–5252. doi: 10.1128/iai.62.12.5247-5254.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chou H., Lin W.L., Tam M.F., Wang S.R., Han S.H., Shen H.D. Alkaline serine proteinase is a major allergen ofAspergillus flavus, a prevalent airborneAspergillus species in the Taipei area. Int. Arch. Allergy. Immunol. 1999;119:282–290. doi: 10.1159/000024205. [DOI] [PubMed] [Google Scholar]
  • 14.Palmer L.B., Greenberg H.E., Schiff M.J. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991;46:15–20. doi: 10.1136/thx.46.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Purkayastha S., Madan T., Shah A., Krishnamurthy H.G., Sarma P.U. Multifunctional antigens ofA. fumigatus and specific antibodies. App. Biochem. Biotech. 2000;83:271–284. doi: 10.1385/ABAB:83:1-3:271. [DOI] [PubMed] [Google Scholar]
  • 16.Singh P., Kumar P., Bhagi R.P., Singla R. Pulmonary aspergilloma-radiological observations. Ind. J. Chest. Dis. Allied. Sci. 1989;31:177–185. [PubMed] [Google Scholar]
  • 17.Ommen G.J.B., Bakker E., Dunnen J.T. The human genome project and the future of diagnostics, treatment, and prevention. Lancet. 1999;354:5–10. doi: 10.1016/S0140-6736(99)90241-6. [DOI] [PubMed] [Google Scholar]
  • 18.Wilkins M. Proteomic paradigms for perceiving purpose. TIBTECH. 2000;18:91–92. [Google Scholar]
  • 19.Bellamy R. Genetics and pulmonary medicine. 3. Genetic susceptibility to tuberculosis in human populations. Thorax. 1998;53:588–593. doi: 10.1136/thx.53.7.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bellamy R., Ruwende C., Corrah T., McAdam K.P., Whittle H.C., Hill A.V. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. New Engl. J. Med. 1998;338:640–644. doi: 10.1056/NEJM199803053381002. [DOI] [PubMed] [Google Scholar]
  • 21.Chauhan B., Knutsen A.P., Hutcheson P.S., Slavin R.G., Bellone C.J. T cell subsets, Epitope mapping and HLA-restriction in patients with ABPA. J. Clin. Invest. 1996;97:2324–2331. doi: 10.1172/JCI118675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Knutsen A.P., Hutcheson P.S., Mueller K.R., Slavin R.G. Serum immunoglobulins G anti-Aspergillus fumigatus antibody in patients with cystic fibrosis who have allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 1990;116:724–727. [PubMed] [Google Scholar]
  • 23.Miller P.W., Hamosh A., Macek M., Greenberger P.A., Maclean J., Walden S.M., Slavin R.G., Cutting G.R. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Amer. J. Hum. Genet. 1996;59:45–51. [PMC free article] [PubMed] [Google Scholar]
  • 24.Madan T., Eggleton P., Kishore U., Aggarwal S.S., Sarma P.U., Reid K.B.M. Binding of pulmonary surfactant protein A and D toAspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and macrophages. Infect. Immun. 1997;65:3171–3179. doi: 10.1128/iai.65.8.3171-3179.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Madan T., Kishore U., Eggleton P., Aggarwal S.S., Sarma P.U., Reid K.B.M. Interaction of lung surfactant protein SP-A and SP-D with allergens ofAspergillus fumigatus. J. Clin. Exp. Immunol. 1997;110:241–249. doi: 10.1111/j.1365-2249.1997.tb08323.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES